These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22856325)

  • 1. Decision-making in healthcare: a practical application of partial least square path modelling to coverage of newborn screening programmes.
    Fischer KE
    BMC Med Inform Decis Mak; 2012 Aug; 12():83. PubMed ID: 22856325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Link between process and appraisal in coverage decisions: an analysis with structural equation modeling.
    Fischer KE; Stollenwerk B; Rogowski WH
    Med Decis Making; 2013 Nov; 33(8):1009-25. PubMed ID: 23771882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Funding decisions for newborn screening: a comparative review of 22 decision processes in Europe.
    Fischer KE; Rogowski WH
    Int J Environ Res Public Health; 2014 May; 11(5):5403-30. PubMed ID: 24852389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of health technology assessment in coverage decisions on newborn screening.
    Fischer KE; Grosse SD; Rogowski WH
    Int J Technol Assess Health Care; 2011 Oct; 27(4):313-21. PubMed ID: 22004771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study.
    Wagner M; Samaha D; Casciano R; Brougham M; Abrishami P; Petrie C; Avouac B; Mantovani L; Sarría-Santamera A; Kind P; Schlander M; Tringali M
    Int J Health Policy Manag; 2019 Jul; 8(7):424-443. PubMed ID: 31441279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To fund or not to fund: development of a decision-making framework for the coverage of new health technologies.
    Stafinski T; Menon D; McCabe C; Philippon DJ
    Pharmacoeconomics; 2011 Sep; 29(9):771-80. PubMed ID: 21756008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transparency vs. closed-door policy: do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis.
    Fischer KE; Rogowski WH; Leidl R; Stollenwerk B
    Health Policy; 2013 Oct; 112(3):187-96. PubMed ID: 23664301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review and critique of modelling in prioritising and designing screening programmes.
    Karnon J; Goyder E; Tappenden P; McPhie S; Towers I; Brazier J; Madan J
    Health Technol Assess; 2007 Dec; 11(52):iii-iv, ix-xi, 1-145. PubMed ID: 18031651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of reliable and valid tools for the measurement of patient participation in healthcare.
    Phillips NM; Street M; Haesler E
    BMJ Qual Saf; 2016 Feb; 25(2):110-7. PubMed ID: 26415751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for improving the adoption of shared decision making by healthcare professionals.
    Légaré F; Ratté S; Stacey D; Kryworuchko J; Gravel K; Graham ID; Turcotte S
    Cochrane Database Syst Rev; 2010 May; (5):CD006732. PubMed ID: 20464744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fairness and accountability for reasonableness. Do the views of priority setting decision makers differ across health systems and levels of decision making?
    Kapiriri L; Norheim OF; Martin DK
    Soc Sci Med; 2009 Feb; 68(4):766-73. PubMed ID: 19070414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of coverage decision-making on health technologies-evidence from the real world.
    Fischer KE
    Health Policy; 2012 Oct; 107(2-3):218-30. PubMed ID: 22867939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priority setting and cardiac surgery: a qualitative case study.
    Walton NA; Martin DK; Peter EH; Pringle DM; Singer PA
    Health Policy; 2007 Mar; 80(3):444-58. PubMed ID: 16757057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Falls prevention for the elderly.
    Balzer K; Bremer M; Schramm S; Lühmann D; Raspe H
    GMS Health Technol Assess; 2012; 8():Doc01. PubMed ID: 22536299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels.
    van Velden ME; Severens JL; Novak A
    Pharmacoeconomics; 2005; 23(11):1075-82. PubMed ID: 16277545
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.